Chemotherapy combined with radiotherapy is the traditional treatment for oropharyngeal cancer. All cancer treatments can have side effects, but radiotherapy for this form of the disease often ...
Hisham Mehanna, a professor at the University of Birmingham's Institute of Cancer and Genomic Sciences, has conducted ...
A recent research by Hisham Mehanna, Professor at the Institute of Cancer and Genomic Sciences, University of Birmingham, has ...
A alarming trend has emerged in the medical community, with oral sex being identified as the leading cause of throat cancer, ...
Oral sex has now been identified as the leading cause of throat cancer, overtaking smoking, alcohol consumption, and poor ...
Knowledge of the association between human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma (OPSCC) is poor and ...
Oral sex is causing an "epidemic" of throat cancer, with the practice being more damaging than smoking, boozing and a bad diet.
DPXE-7 is under clinical development by BioVaxys Technology and currently in Phase II for Oropharyngeal Cancer.
Ligufalimab is under clinical development by Akeso and currently in Phase II for Oropharyngeal Cancer. According to GlobalData, Phase II drugs for Oropharyngeal Cancer have a 50% phase transition ...
The Human Papillomavirus commonly known as HPV impacts men as much as it impacts women but topics such as HPV in men and ...
January marks Cervical Cancer Awareness Month, a time to focus on the importance of prevention and early detection. One of ...
Researchers observed a dose-response relationship between daily tea consumption and the risk of head and neck cancer, hypopharyngeal cancer, and laryngeal cancer.